Latest Breaking News On - Syndax pharmaceuticals - Page 2 : comparemela.com

The Escalator: Eli Lilly, Teva, Vertex Pharmaceuticals and more

See which leaders are on the move across the pharma, biotech and medical marketing industries.

United statesSrinivas raoJosea moreno toscanoAlana pulverSimona skerjanecMichael obrienLetena lindsayThomas dubinShao lee linEli lillyDara buschJamie avalonPeter delorenzoRob sobieApril quinnSandra milligan

Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Down 3 7%

Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Down 3 7%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkSyndax pharmaceuticals incSyndax pharmaceuticalsChina universal asset management coInstitutional trading of syndax pharmaceuticalsJpmorgan chase coNews ratings for syndax pharmaceuticals dailySyndax pharmaceuticals price performanceSei investments coSyndax pharmaceuticals company profileYork state common retirement fundGet free reportRetirement systemState retirement systemUniversal asset management

Syndax Pharmaceuticals, Inc (NASDAQ:SNDX) to Post Q2 2024 Earnings of ($0 96) Per Share, B Riley Forecasts

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) – Stock analysts at B. Riley lifted their Q2 2024 earnings per share estimates for shares of Syndax Pharmaceuticals in a research note issued on Thursday, May 9th. B. Riley analyst K. Patel now forecasts that the company will earn ($0.96) per share for the quarter, up from […]

Stifel nicolausSyndax pharmaceuticals company profileSyndax pharmaceuticals incQuadrant capital groupAnnandale capitalSyndax pharmaceuticals stock performanceMeadowbrook investment advisorsInstitutional trading of syndax pharmaceuticalsSyndax pharmaceuticalsNews ratings for syndax pharmaceuticals dailyChina universal asset management coFree reportSyndax pharmaceuticalGet free reportUniversal asset managementBrook investment advisors

Syndax Pharmaceuticals (NASDAQ:SNDX) PT Lowered to $30 00 at Citigroup

Syndax Pharmaceuticals (NASDAQ:SNDX) PT Lowered to $30 00 at Citigroup
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

United statesStifel nicolausSyndax pharmaceuticals incSyndax pharmaceuticalsSyndax pharmaceuticals stock performanceYelin lapidot holdings management ltdChina universal asset management coMirae asset global investments coJpmorgan chase coNews ratings for syndax pharmaceuticals dailySg americas securitiesAnalyst recommendations for syndax pharmaceuticalsFree reportModerate buyGet free reportAsset global investments

Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Rating Reaffirmed by HC Wainwright

Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Rating Reaffirmed by HC Wainwright
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesSyndax pharmaceuticals incSg americas securitiesSyndax pharmaceuticals price performanceChina universal asset management coJpmorgan chase coMirae asset global investments coNews ratings for syndax pharmaceuticals dailyInstitutional trading of syndax pharmaceuticalsYelin lapidot holdings management ltdAnalyst recommendations for syndax pharmaceuticalsSyndax pharmaceuticalsFree reportModerate buyGet free reportAsset global investments